RaySearch Laboratories AB (publ)
RSLBF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $7,236 | $3,211 | $1,962 | $2,036 |
| - Cash | $463 | $344 | $160 | $103 |
| + Debt | $472 | $529 | $555 | $561 |
| Enterprise Value | $7,245 | $3,396 | $2,357 | $2,495 |
| Revenue | $1,192 | $1,022 | $844 | $642 |
| % Growth | 16.6% | 21.2% | 31.5% | – |
| Gross Profit | $1,093 | $916 | $749 | $591 |
| % Margin | 91.7% | 89.6% | 88.7% | 92.1% |
| EBITDA | $571 | $406 | $341 | $197 |
| % Margin | 47.9% | 39.7% | 40.4% | 30.8% |
| Net Income | $204 | $82 | $24 | -$47 |
| % Margin | 17.1% | 8% | 2.8% | -7.4% |
| EPS Diluted | 5.94 | 2.38 | 0.69 | -1.38 |
| % Growth | 149.6% | 244.9% | 150% | – |
| Operating Cash Flow | $485 | $456 | $357 | $238 |
| Capital Expenditures | -$218 | -$209 | -$232 | -$255 |
| Free Cash Flow | $268 | $247 | $125 | -$17 |